Cystic fibrosis is a common, fatal genetic disease in which a gene causes the body to produce abnormally thick, sticky mucus. This affects mainly the lungs, causing severe breathing problems, and the ...

New data shows three triple-combination regimens are "highly effective" for up to 90 percent of cystic fibrosis patients.In what medical researchers are calling a first but very important step for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Children aged 12 years and older with cystic fibrosis ...

CLEVELAND, Ohio -- Dr. Michael W. Konstan is the new chairman of the pediatrics department at University Hospitals Case Medical Center’s Rainbow Babies & Children’s Hospital and Case Western Reserve ...

Please provide your email address to receive an email when new articles are posted on . Palivizumab — a monoclonal antibody that prevents respiratory syncytial virus, or RSV, in high-risk infants — ...

The Division of Pulmonary Medicine within Saint Louis University's Department of Pediatrics cares for children with a variety of acquired and congenital respiratory disorders as well as sleep ...

The U.S. Food and Drug Administration today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic ...

As a parent, watching a child suffer from a respiratory disorder can be frightening and worrisome. Our respiratory specialists provide compassionate care for a wide-range of pediatric respiratory ...

BUFFALO, N.Y. – Drucy S. Borowitz, MD, clinical professor in the Department of Pediatrics in the University at Buffalo School of Medicine and Biomedical Sciences, has received a major national award ...

In cystic fibrosis, Pseudomonas aeruginosa is a much-feared pathogen. The bacterium easily colonizes the lungs of people with cystic fibrosis, leading to chronic infections that are almost impossible ...

Cystic fibrosis is more deadly for Hispanic than non-Hispanic patients, a disparity that is not explained by differences in their access to health care, according to a new study from the Stanford ...